SPC waiver stockpiling provision attracts criticism

While the final text of the European Council’s agreement on a supplementary protection certificate (SPC) manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Generics

European Parliament approves SPC manufacturing waiver

18 April 2019 The European Parliament has voted to approve the supplementary protection certificate manufacturing waiver, which will allow the stockpiling of generic versions of patented drugs.

Generics

European Council agrees on SPC manufacturing waiver

15 February 2019 The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals.

Big Pharma

EU committee approves SPC waiver

24 January 2019 The Legal Committee of the European Parliament has voted in favour of the proposed supplementary protection certificate waiver.